Rezzan Hekmat, MHS

Articles by Rezzan Hekmat, MHS

Real-World Use of an Artificial Intelligence-Supported Solution for Coding of Adverse Events in Clinical Trials

ByBrett R. South, MS, PhD,Courtney VanHouten, MA,Van C. Willis, PhD,Walker Bradham,Jennifer Duff, MBA,Rezzan Hekmat, MHS,Jane L. Snowdon, PhD, FAMIA,Dilhan Weeraratne, PhD

April 12th 2022

Study evaluates the use of AI-supported medical coding module.

Accelerating Clinical Trial Design and Operations

ByRezzan Hekmat, MHS,Nawshin Kutub, PhD,Courtney VanHouten, MA,Ryad Ramda, MS,Van C. Willis, PhD,Gretchen P. Jackson, MD, PhD,Cindy Henderson,Dilhan Weeraratne, PhD,Robert A. DiCicco, PharmD,Jane L. Snowdon, PhD, FAMIA

March 9th 2021

Fully-integrated, component-based CDMS offers flexibility, customization, and efficiency.

Latest Updated Articles

Accelerating Clinical Trial Design and Operations
Published: March 9th 2021 | Updated:
Real-World Use of an Artificial Intelligence-Supported Solution for Coding of Adverse Events in Clinical Trials
Published: April 12th 2022 | Updated:

Trending on Applied Clinical Trials Online

NIH Implements Contingency Plan as Government Shutdown Impacts Research Funding

Assay Reproducibility in Hemostasis Diagnostics: Practical Methods to Reduce Variability and Strengthen Trial Outcomes

2025 SCRS Global Site Solutions Summit: How Technology Vendors Can Reduce Site Burden and Improve Trial Execution

2025 SCRS Global Site Solutions Summit: Best Practices for Building Strong Site Partnerships and Choosing the Right Technology

ACT Brief Weekly Recap: AI Monitoring, Biotech Scaling, and Site Interoperability Lead This Week’s Top Stories

© 2025 MJH Life Sciences^®

All rights reserved.